Expression of exposure in negative carcinogenicity studies: dose/body weight, dose/body surface area, or plasma concentrations?
about
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.The use of toxicokinetic data in preclinical safety assessment: a toxicologic pathologist perspectivePerspective on the carcinogenic potential of phenytoin based on rodent tumor bioassays and human epidemiological data.Allometric metabolic scaling and fetal and placental weight
P2860
Expression of exposure in negative carcinogenicity studies: dose/body weight, dose/body surface area, or plasma concentrations?
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Expression of exposure in nega ...... rea, or plasma concentrations?
@en
type
label
Expression of exposure in nega ...... rea, or plasma concentrations?
@en
prefLabel
Expression of exposure in nega ...... rea, or plasma concentrations?
@en
P2860
P1476
Expression of exposure in nega ...... rea, or plasma concentrations?
@en
P2093
P2860
P304
P356
10.1177/019262339502300213
P407
P577
1995-03-01T00:00:00Z